​Where Everyone Agrees on Marijuana

Rodney Johnson  |

Thank goodness election day is over!

Maybe we’ll get a reprieve from all the idiot, hype-infested political advertising. This election season has done something I thought was impossible. It’s made me long for traditional advertising, where retailers tell me that I’ll be smarter/better/thinner/richer/whatever if I just buy their product.

We need a new gizmo, a political TiVo. It doesn’t have to skip over the political ads, although that would be nice. It could simply replace the ads with a more soothing sound, like crying babies or chainsaws at full throttle.

And it’s not just television. I get ads all day across my computer when surfing the net, and even on my cell phone.

I realize that the price of using web browsers for free is that I give up my soul to digital marketing, but my phone? That’s not free. I pay dearly for it.

It’s not right that I can be hounded incessantly by marketers that I’ve tried to block. We need a product for this as well. Maybe something that includes a cattle prod and high voltage.

But I’m off topic…

It’s election day, and we have all of those ads because we’re a house that’s almost evenly divided. And neither side shows much interest in shuffling toward the middle.

Almost every issue is a point of contention, but not all.

Marijuana is on the ballot in four states, with North Dakota and Michigan voting on recreational adult use, while Utah and Missouri vote on access to medical marijuana. Other jurisdictions, such as Ohio and some counties in Wisconsin, are voting to decriminalize pot. It seems on this issue that most Americans agree.

In 2011, 50% of us thought marijuana should remain illegal, while just over 40% wanted to legalize the drug. The rest were undecided.

Now, more than 60% want to legalize pot, with less than 40% against.

Even at our recent Irrational Economic Summit, the crowd was overwhelmingly in favor. During an electronic poll, 53% of the attendees voted for medical marijuana, 40% for recreational, and only 7% against any legal access. Lumping the medical and recreational together, that was a 93% vote for legal pot.

Recreational marijuana is already legal nine states and the District of Columbia, while 31 states and D.C. have approved medical marijuana. The votes in the four states mentioned above will certainly add at least two more to those numbers.

As I told the audience at our conference two weeks ago, marijuana has not changed. It’s the same plant, same drug, that has been used (and abused) by people for more than 5,000 years.

Instead, we have changed. Or should I say, our attitude has changed. We’re learning, or possibly relearning, some of the benefits of medical marijuana, and many of today’s decision makers were yesterday’s hippies. They used marijuana in their youth, lived to tell the tale, and think of it as on par with alcohol, not crack or LSD.

Because the U.S. government still classifies marijuana as a Schedule I drug, we don’t have a lot of research on its long-term effects. As voters legalize it around the country, we’ll find out more.

We’ll also see many businesses spring up to take advantage of the newly opened markets, eventually giving us investing opportunities. I’ll be following these closely in the months ahead.

That’s one good thing that might come out of this year’s hard-fought election cycle. It’s enough to make some people want to smoke pot… and watch television.

Rodney

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

What Is Petrolithium?

MGX Minerals explains the advantages of petrolithium and how they are helping to solve future problems today.

Emerging Growth

Investview Inc

Investview Inc is an investor technology and education company. It provides products that allow the individual investor to find, analyze, track, and manage their portfolio.